We integrate cell-based approaches with "omics" technologies to study noncoding RNA behavior.

We measure RNA structure and RNA-protein interactions through chemical probes that react with RNAs in cells.

We define aberrations in the RNA-binding proteome (RBPome) that govern disease by mass spectrometry.